Cases & Deals

  • Home
  • Practices
  • Chinese drug discovery company signs license and research services agreement with U.S.-based multinational biopharmaceutical company for antibody therapeutics

Share

Chinese drug discovery company signs license and research services agreement with U.S.-based multinational biopharmaceutical company for antibody therapeutics

December 2025

Client(s) Leading Chinese drug discovery and development company

Jones Day represented a leading Chinese drug discovery and development company in negotiating an outbound exclusive license and research services agreement with a U.S.-based multinational biopharmaceutical company involving an innovative antibody therapeutic for treating autoimmune diseases.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.